Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.845
-0.035 (-1.86%)
Nov 21, 2024, 11:58 AM EST - Market open
Virax Biolabs Group Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Net Income | -6.73 | -6.73 | -5.46 | -1.71 | -0.65 | -0.71 |
| Depreciation & Amortization | 0.1 | 0.1 | - | - | - | - |
| Asset Writedown & Restructuring Costs | 0.39 | 0.39 | - | - | - | - |
| Stock-Based Compensation | 1.01 | 1.01 | 1.75 | 0.29 | - | - |
| Other Operating Activities | 0.1 | 0.1 | -0.29 | -0.03 | 0 | 0.06 |
| Change in Accounts Receivable | - | - | - | 0 | -0 | - |
| Change in Inventory | -0.06 | -0.06 | 0.02 | 0 | -0.02 | - |
| Change in Accounts Payable | -0.57 | -0.57 | 0.03 | 0.64 | 0.08 | -0.1 |
| Change in Unearned Revenue | -0.04 | -0.04 | 0.04 | - | - | - |
| Change in Other Net Operating Assets | -0.45 | -0.45 | -0.28 | 0 | - | - |
| Operating Cash Flow | -6.25 | -6.25 | -4.18 | -0.81 | -0.59 | -0.74 |
| Capital Expenditures | -0.95 | -0.95 | - | - | - | - |
| Sale (Purchase) of Intangibles | -0.21 | -0.21 | -0.18 | - | - | - |
| Investing Cash Flow | -1.16 | -1.16 | -0.18 | - | - | - |
| Short-Term Debt Issued | - | - | 0.49 | 0.29 | 0.18 | 0.7 |
| Total Debt Issued | - | - | 0.49 | 0.29 | 0.18 | 0.7 |
| Short-Term Debt Repaid | -0.17 | -0.17 | -0.45 | - | - | - |
| Long-Term Debt Repaid | -0.06 | -0.06 | - | - | - | - |
| Total Debt Repaid | -0.22 | -0.22 | -0.45 | - | - | - |
| Net Debt Issued (Repaid) | -0.22 | -0.22 | 0.03 | 0.29 | 0.18 | 0.7 |
| Issuance of Common Stock | 0 | 0 | 13.65 | 0.52 | 0.4 | - |
| Other Financing Activities | 1.87 | 1.87 | - | - | - | - |
| Financing Cash Flow | 1.65 | 1.65 | 13.69 | 0.81 | 0.59 | 0.7 |
| Net Cash Flow | -5.76 | -5.76 | 9.33 | 0 | -0 | -0.04 |
| Free Cash Flow | -7.2 | -7.2 | -4.18 | -0.81 | -0.59 | -0.74 |
| Free Cash Flow Margin | -4602.71% | -4602.71% | -48823.35% | - | -476.65% | -745.54% |
| Free Cash Flow Per Share | -3.59 | -3.59 | -3.93 | -0.85 | -2.45 | -7.13 |
| Cash Interest Paid | 0.01 | 0.01 | 0.02 | - | - | - |
| Levered Free Cash Flow | -4.99 | -4.99 | -2.73 | -0.25 | -0.23 | - |
| Unlevered Free Cash Flow | -4.97 | -4.97 | -2.72 | -0.24 | -0.21 | - |
| Change in Net Working Capital | 1.1 | 1.1 | 0.71 | -0.55 | -0.19 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.